Carter Charles Ross 4
4 · CERO THERAPEUTICS HOLDINGS, INC. · Filed Mar 27, 2024
Insider Transaction Report
Form 4
Carter Charles Ross
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-03-25+395,387→ 395,387 totalExercise: $1.77Exp: 2034-03-24→ Common Stock (395,387 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in forty-eight (48) monthly installments following the grant date, subject to the Reporting Person's continued service on each such vesting date.